Nov-2019 |
Abcam agrees to acquire Expedeon’s Proteomics and Immunology business, expanding offerings into the fast-growing conjugation segment
|
Nov-2019 |
Abcam and BrickBio announce a partnership to incorporate conjugation-ready sites into recombinant antibodies across Abcam's portfolio
|
Nov-2019 |
Engineered knockout cell lysates for reproducible proteomic analysis
|
Jul-2019 |
Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio
|
May-2019 |
New tissue clearing kits and reagents for faster, accurate 3D imaging
|
Apr-2019 |
NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler
|
Mar-2019 |
Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging
|
Mar-2019 |
Abcam wins the UK-China Business award
|
Feb-2019 |
Abcam moves to new purpose-built global headquarters
|
Feb-2019 |
Dr Michael Weiner wins CiteAb’s 2019 Lifetime achievement award
|
Jan-2019 |
Abcam expands custom services capabilities with the
acquisition of Calico Biolabs
|
Jan-2019 |
Abcam and the LouLou Foundation partner to develop key research tools for CDKL5 deficiency disorder
|
Dec-2018 |
QIAGEN (Suzhou) and Abcam sign strategic MoU collaboration agreement to co-develop companion diagnostic (CDx) and in vitro diagnostic (IVD) reagents and kits for the Chinese market
|
Dec-2018 |
Abcam 'Most Admired Company' award
|
Oct-2018 |
Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development
|
Oct-2018 |
New PBS-only antibodies enable more flexible research
|
Jul-2018 |
Abcam Merck collaboration produces new PD-L1 antibody for immuno-oncology research
|
Jun-2018 |
Congratulations to Alan Hirzel, winner of European Mediscience Awards Chief Executive of the year award
|
Apr-2018 |
Abcam and Shuwen Biotech sign strategic MoU to establish global alliance for companion diagnostic (CDx) kit development
|
Feb-2018 |
New CatchPoint® SimpleStep® ELISA fluorescent 90-minute assay
|
Feb-2018 |
Introducing FirePlex®-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples
|
Feb-2018 |
Abcam and Molecular Devices announce strategic collaboration
|
Jan-2018 |
Abcam wins another CiteAb award
|
Jan-2018 |
Abcam signs exclusive license agreement with Roche
|
Aug-2017 |
Abcam and TTP Labtech collaborate to develop sol-R reagent kits
|
Jul-2017 |
The University of Bath enters licensing agreement with Abcam to develop fluorescent detection probe kit for sugar-damaged proteins
|
Jun-2017 |
Abcam announces first international Epigenetics conference in South Korea
|
Jan-2017 |
Abcam wins two CiteAb awards
|
Nov-2016 |
Abcam wins Best Careers Website at the In-house Recruitment Awards
|
Jul-2016 |
New multiplex immunoassays with Firefly® particle technology
|
Apr-2016 |
Abcam enables faster drug and biomarker discovery with immunoassay research suite
|
Feb-2016 |
Congratulations to Jonathan Milner, winner of CiteAb’s Lifetime achievement award
|
Nov-2015 |
Abcam offers direct service to Singapore as part of deepening commitment to Asia-Pacific researchers
|
Nov-2015 |
Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership
|
Oct-2015 |
Abcam’s new anti-PD-L1 antibody enables deeper insights into cancer immunology research
|
Sep-2015 |
Abcam raises antibody validation standards to improve quality for life science researchers
|
Jun-2015 |
Appointment of Chief Legal Officer and Company Secretary
|
Jun-2015 |
Abcam launches multiplex miRNA profiling assays
|
Jan-2015 |
Abcam signs exclusive partnership agreement with A*STAR's Institute of Molecular and Cell Biology
|
Dec-2014 |
Sue Harris appointed as non-Executive Director on Abcam Board
|
Dec-2014 |
Abcam appoints Yvonne Chien as Chief Digital Officer
|
Nov-2014 |
Abcam wins 'Best Use of Digital Media' at Life Science Industry Awards
|
Sep-2014 |
Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute
|
Sep-2014 |
Abcam plc announces appointment of new CEO and Board changes
|
Sep-2014 |
Abcam and Cell Marque sign global strategic marketing agreement for IVD IHC RabMAb® antibodies
|
Sep-2014 |
Abcam introduces exclusive range of highly validated antibody conjugates
|
Aug-2014 |
Abcam establishes new direct service for Australia and New Zealand
|
Jun-2014 |
Abcam's CEO wins Mediscience award
|
Mar-2014 |
Abcam introduces Alexa Fluor® 680/790 secondary antibodies for fluorescent western blotting
|
Feb-2014 |
Abcam Announces Winner of 15 Discoveries Contest
|
Jan-2014 |
Abcam to open office in Shanghai, China
|
Dec-2013 |
Abcam wins 'Most Admired Company' award
|
Nov-2013 |
Abcam Introduces Alexa Fluor Secondary Antibodies
|
Oct-2013 |
Abcam Named AIM Company of the Year
|
Sep-2013 |
Abcam Launches SimpleStep ELISA Kits
|
Jun-2013 |
Abcam appoints Alan Hirzel as Chief Marketing Officer
|
Apr-2013 |
Abcam Welcomes Students from Cambridge Regional College
|
Mar-2013 |
Abcam donates an additional £45,000 to local charities
|
Dec-2012 |
Abcam helps contribute to growth of hi-tech sector in Cambridge, UK
|
Nov-2012 |
We have reached 100,000 products
|
Oct-2012 |
HRH The Duke of York visits Abcam to see the Cambridge Phenomenon in action
|
Sep-2012 |
Rabbit monoclonal antibodies, available from Abcam following acquisition of Epitomics
|
Jan-2012 |
New range of Biochemicals now available from Abcam
|
Sep-2011 |
Abcam acquires Ascent Scientific, a specialist provider of biochemicals
|
May-2011 |
Abcam acquires MitoSciences in deal which enhances immunoassay portfolio
|
Nov-2010 |
Jonathan Milner wins Entrepreneur of the Year award.
|
Jul-2010 |
Abcam's Jonathan Milner wins CEO of the Year
|
Jul-2010 |
300th employee hired
|
Mar-2010 |
Abcam wins 'Business of the Year 2009' at the Business Weekly East of England Awards.
|
Feb-2010 |
Abcam founder wins 'CEO of the Year' at Quoted Company Awards 2010
|
Jan-2010 |
Abcam and Cambridge Design Partnership develop innovative labeling solution
|
Oct-2009 |
Abcam named 'Company of the Year' at 2009 AIM Awards
|
Jun-2009 |
Abcam’s expansion continues with its fourth move on the Cambridge Science Park
|
Nov-2008 |
Winners of tenth anniversary competition announced
|
Jul-2008 |
200th employee hired
|
May-2008 |
Licensing deal signed with Tepnel Life Sciences
|
Mar-2008 |
Grand setting for Japanese sub-dealer meetings
|
Nov-2007 |
Automated system to expand monoclonal production
|
Nov-2007 |
Abcam and leading antibody producer collaborate to make 12,000 rabbit polyclonals
|
Nov-2007 |
CLC bio customized software supports Abcam's monoclonal development capability
|
Nov-2007 |
Jeffrey Iliffe appointed as Chief Financial Officer
|
May-2007 |
Same day delivery in Cambridge UK
|
Mar-2007 |
Over 30,000 products in our catalog
|
Mar-2007 |
Abcam to partner in the EPITRON project
|
Jan-2007 |
$2 to Médecins Sans Frontières for every new registration
|
Jul-2006 |
Extra Abpoints introduced for first Abreviews
|
Jul-2006 |
Appointment of Non-Executive Directors
|
Jun-2006 |
Winner of Best Newcomer in the UK techMARK mediscience awards
|
May-2006 |
Better antibodies, faster
|
Feb-2006 |
Winner of Private Company of the Year, Business Weekly East of England Business Awards 2005
|
Feb-2006 |
20,000+ products, 1,300 new lysates, Abpromise stats, Abupdate & news
|
Jan-2006 |
Fast Abpromise support, free loading control samples, Abupdate & news
|
Nov-2005 |
Search filter, conjugated loading controls, Abupdate & news
|
Oct-2005 |
Extended North America customer service hours
|
Sep-2005 |
Top forty position, Sunday Times Microsoft Tech Track
|
May-2005 |
US office on the move
|
Apr-2005 |
Queen's Award at first attempt
|
Apr-2005 |
More space
|
Dec-2004 |
A faster service
|
Oct-2004 |
First place in Deloitte's Fast 50
|
Sep-2004 |
50th employee hired
|
Sep-2004 |
Top forty position, Sunday Times Microsoft Tech Track
|
Jun-2004 |
Jim Warwick becomes Managing Director (Abcam Ltd)
|
Feb-2004 |
Collaboration deal struck with Purely Proteins
|
Jan-2004 |
A New Year's Honour
|
Dec-2003 |
High growth status recognised again, this time nationally
|
Oct-2003 |
Success in Deloitte's Regional Technology Fast 50
|
Sep-2003 |
Top twenty position, Sunday Times Arm Tech Track
|
Jul-2003 |
British royalty visits Abcam
|
May-2003 |
First overseas office established
|
Apr-2003 |
Jim Warwick (Technical Director) becomes full-time
|
Mar-2003 |
CEN Business Excellence Awards winner
|
Mar-2003 |
25th employee hired
|
Feb-2003 |
On the move again
|
Nov-2002 |
Deloitte Top 50 regional winner
|
Aug-2002 |
FedEx tie-up boosts customer support services
|
Jun-2001 |
Technical Director appointed
|
May-2001 |
UK Online for Business Award, highly commended
|
Oct-2000 |
CEN Millennium Business Excellence Awards finalist
|
May-2000 |
10th employee hired
|
Apr-2000 |
Finance Director appointed
|
Mar-2000 |
New premises on the Cambridge Science Park
|
Oct-1999 |
First (of many) awards
|
Oct-1998 |
Open for business
|